December 22, 2009 – The Baylor University Medical Center in Dallas has taken delivery of the Naviscan PEM (positron emission mammography) scanner at its Darlene G. Cass Women’s Imaging Center.

Baylor will utilize PEM scanner to complement its existing anatomical tools by providing a critical 3-D metabolic perspective of breast cancer. The metabolic view allows physicians to distinguish between benign and malignant lesions. A recent multicenter NIH-sponsored study comparing PEM and MRI highlighted that PEM had improved specificity relative to MRI at comparable sensitivity.

The Darlene G. Cass Women’s Imaging Center has been a leading breast imaging service in the Dallas area for more than 20 years, performing more than 50,000 breast imaging procedures annually.

“We recently received prestigious designation as one of five ‘Top Women’s Imaging Centers to Watch in 2009’ from Imaging Technology News acknowledging our commitment to providing the highest level of breast care to our patients,” said Zeeshan Shah, M.D., at Baylor University. “Our leading technology, radiology expertise and our dedication to the detection of breast cancer has allowed us to provide exquisite care to thousands of women. Our expectation is that PEM will prove indispensable to effective breast cancer management for both our referring physicians and our patient population.”

The Naviscan PEM scanner produces high-resolution tomographic images at 2 mm resolution, allowing physicians to visualize breast tumors about the size of a grain of rice. The scanner is the size of a mammography unit and consists of two high-resolution detector heads which are placed in close proximity to the breast. Compared to the higher-force compression necessary for mammography, the Naviscan PEM scanner uses gentle breast immobilization.

For more information: www.naviscan.com


Related Content

News | Radiopharmaceuticals and Tracers

April 5, 2024 — RLS Radiopharmacies, America’s only Joint Commission-accredited radiopharmacy network, today announced ...

Time April 05, 2024
arrow
News | Breast Imaging

April 2, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, announced ...

Time April 02, 2024
arrow
News | Molecular Imaging

March 29, 2024 — Magnetic resonance imaging (MRI) is a cornerstone in the landscape of medical diagnostics, celebrated ...

Time March 29, 2024
arrow
News | Breast Imaging

March 20, 2024 — Interval breast cancer is one that appears between two reviews of a screening program. That is, it is ...

Time March 20, 2024
arrow
News | Breast Imaging

March 15, 2024 — Screening-detected radial scars without atypia at core-needle biopsy (CNB) have a low upstaging rate to ...

Time March 15, 2024
arrow
News | Breast Imaging

March 6, 2024 — There is a pressing need to explore and understand which social determinants of health (SDOH) and health ...

Time March 06, 2024
arrow
News | Radiopharmaceuticals and Tracers

February 21, 2024 — Blue Earth Therapeutics, a Bracco company and emerging leader in the development of innovative next ...

Time February 21, 2024
arrow
News | Breast Imaging

February 20, 2024 — Annual breast cancer screening beginning at age 40 and continuing to at least age 79 results in the ...

Time February 20, 2024
arrow
News | Radiopharmaceuticals and Tracers

February 14, 2024 — PanTera, the Belgian joint venture created by IBA and SCK CEN to secure large-scale production of ...

Time February 14, 2024
arrow
Subscribe Now